Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.898
+0.033 (3.85%)
Nov 20, 2024, 4:00 PM EST - Market closed
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $23.87 million as of November 21, 2024. Its market cap has decreased by -42.07% in one year.
Market Cap
23.87M
Enterprise Value
19.49M
1-Year Change
-42.07%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since November 12, 2012, Tempest Therapeutics's market cap has decreased from $107.00M to $23.87M, a decrease of -77.69%. That is a compound annual growth rate of -11.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 39.20M | -53.72% |
| Dec 29, 2023 | 84.70M | 600.00% |
| Dec 30, 2022 | 12.10M | -66.85% |
| Dec 31, 2021 | 36.50M | -10.32% |
| Dec 31, 2020 | 40.70M | -55.18% |
| Dec 31, 2019 | 90.80M | 377.89% |
| Dec 31, 2018 | 19.00M | -62.00% |
| Dec 29, 2017 | 50.00M | -8.26% |
| Dec 30, 2016 | 54.50M | -79.55% |
| Dec 31, 2015 | 266.50M | -75.22% |
| Dec 31, 2014 | 1.08B | 545.44% |
| Dec 31, 2013 | 166.60M | 39.53% |
| Dec 31, 2012 | 119.40M | 11.59% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 22.48M |
| Akari Therapeutics, | 22.35M |
| Pulmatrix | 22.24M |
| Cocrystal Pharma | 22.08M |
| Enlivex Therapeutics | 22.00M |
| NeurAxis | 21.64M |
| Bionano Genomics | 21.52M |
| Neuronetics | 21.27M |